Sfoglia per AUTORE
TABERNERO J
Collezione AOU Novara

  

Items : 6

Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries. in Journal for immunotherapy of cancer / J Immunother Cancer. 2022 Nov;10(11):e005732. doi: 10.1136/jitc-2022-005732.

2022
AOU Novara

Cortellini A; Dettorre GM; Dafni U; Aguilar-Company J; Castelo-Branco L; Lambertini M; Gennatas S; Angelis V; Sita-Lumsden A; Rogado J; Pedrazzoli P; Viñal D; Prat A; Rossi M; Berardi R; Alonso-Gordoa T; Grisanti S; Dimopoulou G; Queirolo P; Pradervand S; Bertuzzi A; Bower M; Arnold D; Salazar R; Tucci M; Harrington KJ; Mazzoni F; Mukherjee U; Tsourti Z; et alii...

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study. in The Lancet. Oncology / Lancet Oncol. 2022 Jul;23(7):865-875. doi: 10.1016/S1470-2045(22)00273-X. Epub 2022 Jun 2.

2022
AO Alessandria
AOU Novara

Tabernero J; Cortellini A; Provenzano S; Gennari A; Fusco V; Generali D; Grisanti S; Mukherjee U; Diamantis N; Libertini M; Tucci M; Prat A; Rimassa L; Aujayeb A; Grosso F; Parisi A; Queirolo P; Mazzoni F; Caliman E; Santoro A; Giusti R; Zambelli A; Cantini L; Martinez-Vila C; Patriarca A; Bruna R; Ruiz-Camps I; Gaidano G; Fox L; et alii...

Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry. in JAMA oncology / JAMA Oncol. 2022 Jan 1;8(1):114-122. doi: 10.1001/jamaoncol.2021.6199.

2022
AOU Novara

Pinato DJ; Patel M; Scotti L; Colomba E; Dolly S; Loizidou A; Chester J; Mukherjee U; Zambelli A; Dalla Pria A; Aguilar-Company J; Bower M; Salazar R; Bertuzzi A; Brunet J; Lambertini M; Tagliamento M; Pous A; Sita-Lumsden A; Srikandarajah K; Colomba J; Pommeret F; Seguí E; Generali D; Grisanti S; Pedrazzoli P; Rizzo G; Libertini M; Moss C; et alii...

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2022 Aug;171:64-74. doi: 10.1016/j.ejca.2022.04.036. Epub 2022 May 23.

2022
AO Alessandria
AOU Novara

Tabernero J; Cortellini A; Gennari A; Prat A; Rimassa L; Aujayeb A; Queirolo P; Delfanti S; Parisi A; Mazzoni F; Santoro A; Filetti M; Berardi R; Martinez-Vila C; Fusco V; Shawe-Taylor M; Patriarca A; Gaidano G; Ruiz-Camps I; Bruna R; Roldán E; Zoratto F; Fox L; Doonga K; Perachino M; Fort-Culillas R; Saoudi-Gonzalez N; Cruz CA; Yu T; et alii...

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study. in The Lancet. Oncology / Lancet Oncol. 2021 Dec;22(12):1669-1680. doi: 10.1016/S1470-2045(21)00573-8. Epub 2021 Nov 3.

2021
AOU Novara

Tabernero J; Pinato DJ; Bower M; Scotti L; Patel M; Colomba E; Dolly S; Loizidou A; Chester J; Mukherjee U; Zambelli A; Dalla Pria A; Aguilar-Company J; Ottaviani D; Chowdhury A; Merry E; Salazar R; Bertuzzi A; Brunet J; Lambertini M; Tagliamento M; Pous A; Sita-Lumsden A; Srikandarajah K; Colomba J; Pommeret F; Seguí E; Generali D; Grisanti S; et alii...

Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2017 Sep;82:16-24. doi: 10.1016/j.ejca.2017.04.025. Epub 2017 Jun 23.

2017
AOU Città della Salute di Torino
AOU Novara

Laurent-Puig P; Penault-Llorca F; Bennouna J; Allard MA; Boulagnon-Rombi C; Dimet S; Van Laethem JL; Folprecht G; Mini E; Tabernero J; Lepage C; Le Malicot K; Julié C; Emile JF; Taieb J;